55 articles
Karel Styblo
Karel Styblo, a physician who survived tuberculosis in a Nazi concentration camp, built the TB control model that WHO adopted as DOTS in the 1990s.
Keertan Dheda
Keertan Dheda is a South African pulmonologist and tuberculosis researcher who heads pulmonology at the University of Cape Town and Groote Schuur Hospital and directs its Centre for Lung Infection and Immunity.
Lalita Ramakrishnan
Lalita Ramakrishnan is an Indian-born physician-scientist, Professor of Immunology and Infectious Diseases at the University of Cambridge, known for pioneering the zebrafish model of tuberculosis and winning the 2024 Robert Koch Prize.
Lowell S. Young
Lowell S. Young, also known as Lowell Sung-Yi Young, is an American infectious-disease physician and epidemiologist known for decades of mycobacterial disease research at the Kuzell Institute in San Francisco.
Madhukar Pai
Madhukar Pai, also known as Madhu Pai, is a Canadian physician and epidemiologist at McGill University in Montreal who trained in India and works on tuberculosis and global health.
Marcel Behr
Marcel Behr is a Canadian clinician-scientist and Full Professor at McGill University in Montreal who studies tuberculosis genomics, evolution, and epidemiology, and directs McGill's Infectious Diseases Division.
Mario Raviǵlione
Mario Raviǵlione, also known as Mario C. Raviglione, is an Italian physician who directed the WHO Global Tuberculosis Programme from 2003 to 2017, developing the End TB Strategy.
Melvin Spigelman
Melvin Spigelman is a physician and tuberculosis drug-development researcher who serves as President and CEO of the TB Alliance, which developed pretomanid, approved by the FDA in 2019.
Michael S. Glickman
Michael S. Glickman is an American infectious-disease physician and mycobacteriologist at Memorial Sloan Kettering Cancer Center in New York, known for research on how tuberculosis bacteria survive immune attack and antibiotics.
Neil W. Schluger
Neil W. Schluger is an American pulmonologist and tuberculosis researcher, dean of the School of Medicine at New York Medical College since 2023 after leading Columbia's pulmonary division.
Peter F. Barnes
Peter F. Barnes is an American physician-scientist in infectious diseases known for tuberculosis research, including documenting the HIV-driven resurgence of tuberculosis and showing it spread mainly at Los Angeles homeless shelters.
Peter Godfrey‐Faussett
Peter Godfrey-Faussett is an infectious-diseases physician-scientist and Emeritus Professor at the London School of Hygiene & Tropical Medicine, known for tuberculosis and HIV research in Zambia and South Africa.
Peter M. Small
Peter M. Small is an American infectious-disease physician-scientist who established the molecular epidemiology of tuberculosis at UCSF and Stanford, then designed and ran the Gates Foundation's global tuberculosis program.
Richard Chaisson
Richard E. Chaisson is an American infectious-disease physician and epidemiologist at Johns Hopkins University, where he directs the Center for Tuberculosis Research, which he founded in 1998.
Robert Wilkinson (clinician-scientist)
Robert J. Wilkinson is a British clinician-scientist studying tuberculosis and HIV co-infection, whose Cape Town trials changed World Health Organization policy and who was appointed OBE in 2025.
Sabine Ehrt
Sabine Ehrt is a microbiologist who studies how Mycobacterium tuberculosis persists and evades treatment, and became chair of Microbiology and Immunology at Weill Cornell Medicine in 2025.
Sébastien Gagneux
Sébastien Gagneux is a Swiss infectious-disease researcher who leads the Tuberculosis Ecology and Evolution group at Swiss TPH and is a professor at the University of Basel.
Soumya Swaminathan
Soumya Swaminathan is an Indian pediatrician and tuberculosis and HIV researcher who served as the World Health Organization's first Chief Scientist from 2019 to 2022.
Stefan H. E. Kaufmann
Stefan H. E. Kaufmann is a German immunologist and microbiologist known for research on immunity to tuberculosis and for developing the vaccine candidate VPM1002, tested through phase 3 trials.
Stewart T. Cole
Stewart Thomas Cole is a British mycobacterial geneticist known for his pioneering research on M. tuberculosis genomics and his tenure as President of the Institut Pasteur from 2018.
Susan E. Dorman
Susan E. Dorman is an American infectious diseases physician and tuberculosis researcher at the Medical University of South Carolina who led the trial producing the first four-month TB treatment regimen.
Timothy R. Sterling
Timothy R. Sterling is an infectious-diseases physician-scientist at Vanderbilt University Medical Center, director of its Tuberculosis Center, known for the PREVENT TB trial of short-course latent tuberculosis treatment.
Walsh McDermott
Walsh McDermott (1909–1981) was an American infectious disease physician-scientist at Cornell University Medical College, known for tuberculosis research and the Many Farms experiment on the Navajo Nation.
William Hugh Feldman
William Hugh Feldman (1892–1974) was a Scottish-born American veterinary pathologist at the Mayo Clinic who, with Corwin Hinshaw, proved streptomycin could cure tuberculosis in guinea pigs and humans.
William R. Bishai
William R. Bishai, also known as William Bishai, is a physician and professor of medicine at Johns Hopkins who studies the tuberculosis bacterium and co-directs its Center for Tuberculosis Research.